
Reports and Intelligence
Pharmaceutical Chemical Procurement: H1 2026 Closing Intelligence Report
The first half of 2026 reshaped pharmaceutical chemical procurement through supply chain disruptions, rising logistics costs, GLP-1 manufacturing expansion, and evolving regulatory...






